Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.
2.

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM.

JAMA. 1999 May 19;281(19):1822-9.

PMID:
10340370
3.

Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer.

Czoski-Murray C, Karnon J, Jones R, Smith K, Kinghorn G.

Health Technol Assess. 2010 Nov;14(53):iii-iv, ix-x, 1-101. doi: 10.3310/hta14530. Review.

4.

Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients.

Assoumou SA, Mayer KH, Panther L, Linas BP, Kim J.

Sex Transm Dis. 2013 Apr;40(4):298-303. doi: 10.1097/OLQ.0b013e31827f4fe9.

5.

Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.

Goldie SJ, Freedberg KA, Weinstein MC, Wright TC, Kuntz KM.

Am J Med. 2001 Aug;111(2):140-9.

PMID:
11498068
6.

Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV.

Ong JJ, Fairley CK, Carroll S, Walker S, Chen M, Read T, Grulich A, Bradshaw C, Kaldor J, Clarke P.

J Int AIDS Soc. 2016 Mar 1;19(1):20514. doi: 10.7448/IAS.19.1.20514.

7.

Anal cytology as a screening tool for anal squamous intraepithelial lesions.

Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 15;14(5):415-22.

PMID:
9170415
8.

The cost-effectiveness of screening for anal cancer in men who have sex with men: a systematic review.

Howard K.

Sex Health. 2012 Dec;9(6):610-9. doi: 10.1071/SH12017. Review.

PMID:
22951072
10.

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.

11.

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA.

Ann Intern Med. 1999 Jan 19;130(2):97-107.

PMID:
10068381
12.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
13.

Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.

Linas BP, Wong AY, Schackman BR, Kim AY, Freedberg KA.

Clin Infect Dis. 2012 Jul;55(2):279-90. doi: 10.1093/cid/cis382.

14.

Screening and risk factors for anal cancer precursors in men infected with HIV in Taiwan.

Cheng SH, Chu FY, Wang CC, Hsueh YM.

J Med Virol. 2014 Feb;86(2):193-201. doi: 10.1002/jmv.23825.

PMID:
24166485
15.

The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Juusola JL, Brandeau ML, Owens DK, Bendavid E.

Ann Intern Med. 2012 Apr 17;156(8):541-50. doi: 10.7326/0003-4819-156-8-201204170-00001.

16.

Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.

Melnikow J, Kulasingam S, Slee C, Helms LJ, Kuppermann M, Birch S, McGahan CE, Coldman A, Chan BK, Sawaya GF.

Obstet Gynecol. 2010 Nov;116(5):1158-70. doi: 10.1097/AOG.0b013e3181f88e72.

PMID:
20966702
17.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85.

PMID:
15829317
18.
19.

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK.

J Clin Oncol. 2009 Nov 10;27(32):5383-9. doi: 10.1200/JCO.2009.22.8460.

20.

A cost-effectiveness analysis of anal cancer screening in HIV-positive women.

Lazenby GB, Unal ER, Andrews AL, Simpson K.

J Low Genit Tract Dis. 2012 Jul;16(3):275-80. doi: 10.1097/LGT.0b013e31823cde2f.

PMID:
22227844
Items per page

Supplemental Content

Support Center